MEDIVIS

New York, NY, USA All United States companies → — Founded 2016

Medical Device / Hardware Specialty-Focused AI

General Surgery Neurosurgery Orthopedics

Surgical AI

Series A — $22.3M

Website Claim this company

Products

SurgicalAR

MEDIVIS

Surgical AI

SurgicalAR by MEDIVIS is an augmented reality and artificial intelligence platform that provides real-time 3D holographic visualization of patient anatomy directly onto the surgical field, enhancing precision and decision-making during operations.

Contact for pricing

See all 1 product →

About MEDIVIS

MEDIVIS is a leading medical technology company that leverages augmented reality (AR) and artificial intelligence (AI) to revolutionize surgical navigation and visualization. Their flagship platform, SurgicalAR, transforms complex 2D medical imaging data, such as CTs and MRIs, into high-fidelity 3D holographic visualizations that can be overlaid directly onto the patient in real-time. This innovative approach provides surgeons with unprecedented visual guidance, enhancing their understanding of critical anatomy and planned trajectories within the operative field.

For physicians, MEDIVIS’s technology aims to improve surgical precision, increase operator confidence, and ultimately lead to better patient outcomes by reducing complications and operational risks. The company has received FDA clearance for its AR cranial navigation platform, a first for intraoperative guidance in neurosurgery, as well as for its spine navigation system, which supports both open and minimally invasive procedures. They are also developing prostate navigation solutions. The system integrates proprietary computer vision, segmentation, real-time data analysis, and advanced image processing to deliver context-aware guidance, even enabling precise placement of external ventricular drains at the bedside in ICUs.

MEDIVIS’s solutions are designed for seamless clinical integration, compatible with existing systems and off-the-shelf hardware like the Microsoft HoloLens. With deployments in over 40 institutions across North America and Europe, MEDIVIS is committed to establishing augmented reality as a new standard of care, empowering surgeons with real-time information for precise decision-making and reduced operative time, while also accelerating institutional innovation and improving patients’ lives.

What Physicians Need to Know

FDA Clearance

MEDIVIS is the first company to receive FDA 510(k) clearance for augmented reality (AR) navigation in neurosurgery.

Core Technology

Specializes in augmented reality (AR) that overlays 3D patient anatomy directly onto the patient during surgery, providing 'x-ray vision' for surgeons.

AI & Computer Vision

Leverages advanced artificial intelligence (AI) and computer vision to enhance surgical precision, safety, and efficiency.

Surgical Focus

Primarily focused on neurosurgery, offering real-time, intuitive guidance for complex procedures.

Developed by Surgeons

The technology was developed by surgeons, ensuring a deep understanding of clinical needs and seamless integration into existing workflows.

Physician Tip

For physicians, MEDIVIS stands out by offering unparalleled real-time 'x-ray vision' directly on the patient, which can significantly enhance precision and accuracy in neurosurgical procedures. The FDA clearance provides a strong validation of its safety and efficacy. Its intuitive AR guidance, powered by AI, has the potential to reduce operative time, minimize complications, and ultimately improve patient outcomes. The fact that it was developed by surgeons means it's designed with practical clinical utility in mind, integrating seamlessly into current surgical practices without requiring disruptive changes.

MEDIVIS's technology is designed for seamless integration into existing surgical workflows. It is compatible with standard imaging modalities such as CT and MRI, allowing for easy incorporation of pre-operative data into the AR navigation system. The non-invasive tracking eliminates the need for additional hardware on the patient, further simplifying its adoption.

At a glance

Founded 2016

HQ New York, NY, USA · United States

Team size 35

CEO Osamah Choudhry

Funding Series A — $22.3M

Products 1

Visit site

Products by MEDIVIS

1 product in the directory

SurgicalAR

MEDIVIS

Surgical AI

Contact for pricing

Reviews & Opinions

No web reviews on file yet for MEDIVIS. Check back later for aggregated opinions from across the web.

Videos

News, demos, and interviews about MEDIVIS.

Loading videos...

Videos load interactively. If none appear, search YouTube for MEDIVIS →

View all on YouTube

Press & Coverage

PR Newswire

Medivis First to Receive FDA Clearance for Augmented Reality Navigation in Neurosurgery

Medivis Inc. announced it received FDA 510(k) clearance for its Cranial Navigation platform, making it the world's first augmented reality system cleared for intraoperative guidance in cranial neurosurgery. This is their second major FDA clearance this year, following Spine Navigation.

2025-12

NeuroNews International

Medivis receives u201cworld's firstu201d US FDA clearance for AR navigation in cranial neurosurgery

Medivis has received US FDA 510(k) clearance for its cranial navigation platform, marking it as the first augmented reality system for intraoperative guidance in cranial neurosurgery. This follows their spine navigation platform clearance earlier in the year.

2025-12

Fierce Biotech

FDA clears Medivis AR headset platform for neurosurgery navigation - Fierce Biotech

The FDA has cleared Medivis' augmented reality platform for real-time use during brain surgery, a first for the field, building on an earlier clearance for its spine-focused platform. The cranial system, aided by a Microsoft HoloLens headset, enables precise placement of external ventricular drains.

2025-12

PR Newswire

Medivis Receives FDA 510(k) Clearance for Spine Navigation and Announces Commercial Launch in the United States

Medivis Inc. announced it received 510(k) clearance from the U.S. FDA for its Spine Navigation platform, utilizing AR and AI for holographic navigation in spine procedures. The company is also commercially launching Spine Navigation for hospitals and ambulatory surgical centers nationwide.

2025-04

PMC (PubMed Central)

From Data to Decision: A Comprehensive Review of Real-Time Analytics and Smart Technologies in the Surgical Suite - PMC

This review highlights Medivis' Spine Navigation Platform, cleared by the US FDA, which integrates optical and infrared tracking with AR and AI for real-time visualization of instruments in the surgical field. This technology allows surgeons to see holographic representations of instruments and align them with planned trajectories.

2025-10

OrthoFeed

Maia: Pioneering AI-Driven Surgical Assistance in Medicine - OrthoFeed

Medivis is developing Maia, an AI Agent designed to enhance surgical precision and patient outcomes by integrating artificial intelligence with augmented reality. Maia aims to streamline operating room operations and reduce cognitive load on surgeons.

2026-01

PR Newswire

Medivis Raises $20M Series A to Advance Surgery with Augmented Reality

Medivis announced a $20 million Series A funding round led by Thrive Capital, with participation from Initialized Capital and Mayo Clinic, to scale engineering, obtain regulatory clearances, and commercialize globally across multiple surgical specialties.

2023-06

PubMed

Mixed Reality Surgical Navigation System; Positional Accuracy Based on Food and Drug Administration Standard - PubMed

This study assessed the positional accuracy of a clinical mixed reality system by Medivis, utilizing Microsoft HoloLens hardware and Medivis SurgicalAR software. The system demonstrated consistent results with an average accuracy better than one millimeter, exceeding FDA standards for computer-assisted surgical systems.

2023-11

Frequently Asked Questions

What are Medivis's core AI and AR products for surgical applications?

Medivis's flagship product is SurgicalAR, which leverages augmented reality and artificial intelligence to transform 2D medical images into high-fidelity 3D holographic visualizations for surgical planning and intraoperative guidance. They currently offer FDA-cleared solutions for Spine Navigation and Cranial Navigation, with Prostate Navigation in development.

How does Medivis ensure data privacy and regulatory compliance for its AI/AR platforms?

Medivis prioritizes data privacy by offering on-premise IT deployment, ensuring no patient health information (PHI) is stored in the cloud and data remains within the hospital firewall. Their products, such as Spine Navigation and Cranial Navigation, have received FDA 510(k) clearance, demonstrating adherence to regulatory standards for medical devices.

How do Medivis's AR/AI solutions integrate into existing hospital workflows and IT infrastructure?

Medivis's SurgicalAR platform is designed for seamless integration with existing hospital Picture Archiving and Communication Systems (PACS) within a day. The system supports flexible workflow integrations and offers hardware configurations like Medivis PRO for operating rooms and Medivis CORE for ICUs and clinics, ensuring adaptability across various clinical environments.

What are the demonstrated clinical benefits and use cases of Medivis's technology?

Medivis's technology aims to enhance surgical precision, reduce operative time, and improve patient outcomes by providing surgeons with real-time, holographic visualization of patient anatomy. Clinical use cases include surgical planning, patient education, resident training, and remote assistance across specialties like neurosurgery and orthopedics.

How is Medivis's pricing structured, and what are the potential cost implications for healthcare institutions?

Medivis's pricing structures are tailored to each deployment, indicating a customized approach rather than a standardized fee. The company aims to drive incremental cost savings for medical institutions through enhanced surgical precision and efficiency, potentially leading to reduced complications and improved resource utilization.

What kind of support and training does Medivis offer to ensure effective adoption and use of its platforms?

While specific details on support and training programs are not extensively detailed, Medivis's commitment to ongoing updates for their systems and tailored deployment suggests comprehensive support. Their partnerships with major medical centers also imply collaborative efforts in adoption and integration.

What is Medivis's financial standing and long-term vision for its technology?

Medivis, founded in 2016, has demonstrated strong financial backing, raising $22.3 million in funding, including a $20 million Series A round in June 2023 with investors like Mayo Clinic and Thrive Capital. Their long-term vision is to establish augmented reality as the new standard in surgical navigation, expanding globally across multiple specialties.

Can you elaborate on the role of AI in Medivis's products, beyond just AR visualization?

Beyond AR visualization, Medivis integrates AI through features like AI-based Automatic Registration for faster and accurate preoperative planning, and an upcoming AI Agent named Maia. Maia is designed as an intelligent assistant for clinical AI and translational research, aiming to automate repetitive tasks and provide real-time decision support.

Related Companies

Suggest an Edit →